U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980077) titled 'Ivonescimab for the Treatment of Thymic Cancer' on May 12.
Brief Summary: This phase II trial tests how well ivonescimab works in treating patients with thymic carcinoma. Immunotherapy with monoclonal antibodies, such as ivonescimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Study Start Date: June 17
Study Type: INTERVENTIONAL
Condition:
Thymus Carcinoma
Intervention:
PROCEDURE: Biopsy Procedure
Undergo biopsy
PROCEDURE: Biospecimen Collection
Undergo collection of blood and urine samples
PROCEDURE: Computed Tomography
Undergo CT
BIOLOGICAL: ...